期刊文献+

淋球菌对7种抗菌药物敏感性的测定 被引量:2

The Susceptibility of Neisseria Gonorrhoeae to Seven Antibiotic Agents
下载PDF
导出
摘要 目的 了解江门地区淋球菌流行株对抗生素的敏感性 ,为淋病的防治提供试验依据。方法采用琼脂稀释法对 95株淋球菌临床分离株进行了药物敏感性测定。结果 在测定的 7种抗生素中 ,对淋球菌敏感性较高的 5种抗生素依次为阿奇霉素、罗红霉素、红霉素、头孢曲松和壮观霉素 ,其敏感率分别为 1 0 0 .0 %、98.9%、98.9%、95 .8%和 94.7%。而淋球菌耐药性较高的 2种抗生素依次为交沙霉素和头孢唑啉钠 ,耐药率均为 8.4%。结论 阿奇霉素、头孢曲松和壮观霉素仍可作为江门地区淋病治疗的首选药物 ,但淋球菌对头孢曲松和壮观霉素已出现耐药株 ,应引起临床医师的高度警惕 ;罗红霉素、红霉素可作为江门地区淋病治疗的替代性药物。 Objective To evaluate the antibiotic susceptibility of Neisseria gonorrhoeae epidemic strains in jiangmen and to provide a referrence for the prevention and treatment of gonorrhea. Methods 95 gonococcal isolates were tested for their susceptibilities to 7 antibiotic agents using agar dilution method. Result Of all these 7 antibiotic agents , the higher susceptibilities to gonococci were azithromycin , roxithromycin , erythromycin , ceftriaxone , spectinomycin in turn , the percentages of susceptibility were 100.0% , 98.9% , 98.9% , 95.8% , 94.7% respectively .On the other hand , the higher resistances to gonococci were josamycin and cefazolin ,the percentages of resistance were all 8.4%. Conclusion Azithromycin , ceftriaxone and spectinomycin can still be used as primary agents to cure gonorrhea , but clinical doctors need to pay more attention to them , because resistant strains to ceftriaxone and spectinomycin have come into existence. Roxithromycin and erythromycin can be used alternative agents to cure gonorrhea .
出处 《南华大学学报(医学版)》 2004年第3期290-293,共4页 Journal of Nanhua University(Medical Edition)
基金 湖南省教育厅基金资助 (课题编号 :0 2C3 98)
关键词 淋病奈瑟菌 琼脂稀释法 抗生素敏感性 最小抑菌浓度(MIC) Neisseria gonorrhoeae agar dilution antibiotic susceptibility minimum inhibitory concentration(MIC)
  • 相关文献

参考文献12

  • 1National committee for clinical laboratory standards.Performance standards for antimicrobial susceptibility testing ; twelfth informational supplement .M100-S12[S]. Pennsylvania:NCCLS,2002.1-133.
  • 2National committee for clinical laboratory standard(1999).Performance standards for antimicrobial susceptibility testing ; 9th informational supplement . NCCLS document. M100-S9[S]. National Committee for Clinical Laboratory Standards, Wayne , Pa .
  • 3Clendennen TE, Echeverria P, Saengeur S,et al.Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand[J]. Antimicrob Agents Chemother,1992,36:1682-1687.
  • 4叶顺章,苏晓红.淋球菌对头孢三嗪的敏感性测定[J].中国皮肤性病学杂志,1998,12(5):268-269. 被引量:41
  • 5Chevalier BY, Crenn JD, Cavallo N,et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae[J]. Pathol Biol,1995,43:281-283.
  • 6World Health Organization(WHO).Guidelines for the management of sexually transmitted infections[Ⅵ].WHO/HIV-AIDS/2001[M]. Geneva:World Health Organization,2001.32-33.
  • 7Zarantonelli L, Borthagaray G, Lee E H,et al.Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations[J]. Antimicrobial Agents and Chemotherapy , 1999,43:2468-2472.
  • 8Dillon JA, Li H, Sealy J,et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries:Trinidad , Guyana , and St.Vincent[J]. Sex Transm Dis,2001,28(9):508-514.
  • 9Lesmana M, Lebron CI, Taslim D, et al .In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta , Indonesia , Indonesia[J]. Antimicrobial Agents and Chemotherapy, 2001,45(1):359-362.
  • 10Saez-nieto JA, Vazquez JA. In vitro activities of Ketolides HRM 3647 and HRM 3004 , Levofloxacin and Other Quinolones and Macrolides against Neisseria spp and Moraxella catarrhalis[J]. Antimicrobial Agents and Chemotherapy,1999,43(4):983-984.

二级参考文献1

共引文献40

同被引文献29

  • 1赵宏儒,刘艳芳,赵翠英.淋病奈瑟菌耐药性监测[J].河北职工医学院学报,2001,18(2):38-39. 被引量:2
  • 2Zarantonelli L, Borthagaray G, Lee EH, et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 1999 ; 43 (10) : 2468 - 2472.
  • 3Martin IMC, Hoffmann S, Ison CA, et al. European surveillance of sexually transmitted infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. JAC 2006;58:587 - 593.
  • 4Bernstein KT,Marcus JL,Nieri G,et al.Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion[J].J Acquir Immune Defic Syndr,2010,53:537-543.
  • 5World Health Organization.Global incidence and prevalence of selected curable sexually transmitted infections 2008[EB/OL].World Health Organization web site,2008.Available at:http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf.Accessed May 9,2013.
  • 6Japanese Society of Sexually Transmitted Infection.Gonococcal infection,sexually transmitted infections,diagnosis and treatment guidelines 2011[J].Jpn J Sex Transm Dis(Japanese Edition),2011,22(Suppl 1):52-9.
  • 7Centers for Disease Control and Prevention(CDC).Update to CDC’s sexually transmitted diseases treatment guidelines,2010:oral cephalosporins no longer a recommended treatment for gonococcal infections[J].MMWR Morb Mortal Wkly Rep,2012,61:590-594.
  • 8European Centre for Disease Prevention and Control(ECDC).Gonococcal antimicrobial susceptibility surveillance in Europe2010[EB/OL].Stockholm:ECDC,2012.Available at:http://ecdc.europa.eu/en/publications/Publications/1206-GonococcalAMR.pdf(accessed May 4,2013).
  • 9Public Health Agency of Canada.Important Notice-Public Health Information Update on the Treatment of Gonococcal Infection.Public Health Agency of Canada,2011[EB/OL].Available at:http://www.phac-aspc.gc.ca/std-mts/sti-its/alert/2011/alertgono-eng.php.Accessed January 30,2013.
  • 10Goire N,Lahra MM,Ohnishi M,et al.Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89strain[J].Euro Surveill,2013,18(14):20444.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部